In the US, black men are diagnosed with prostate cancer about 70% more often than white men (blacks, 234.4 cases per 100 000; whites, 135.3 per 100 000); prostate cancer mortality is about 130% greater among black than white men (blacks, 55.5 deaths per 100 000; whites, 23.8 per 100 000) (National Cancer Institute, 1997). The causes of prostate cancer are only partially understood and the reasons for the racial differentials in risk are unknown.
proportional to the expected age, sex and race distribution of the combined cases for the four cancer sites. Controls younger than 65 years of age were selected by the Waksberg method of random digit dialling (RDD) (Waksberg, 1978) ; older controls were selected by random sampling from the computerized records of the Health Care Financing Administration.
In total, 1292 cases and 1767 controls were identified for study. In-person interviews were conducted for the cases and controls, usually in their homes. Prostate cancer cases and male controls were questioned about a number of factors, including demographics, height and weight, occupational history, family history of cancer, history of sexually transmitted disease, sexual behaviour, dietary intake, and tobacco and alcohol use. A socio-economic status score (modified from Green, 1970) was derived from review of the reported usual occupation. Interviews were obtained for 988 cases (76%; black = 78%, white = 75%) and 1336 controls (76%; black = 77%, white = 74%). After accounting for non-response in the initial phase of screening for eligibility among RDD contacts, the response rate in controls was 70%. Six cases and six controls were dropped from the analysis due to incomplete interviews. Sixteen subjects (one case, 15 controls) were excluded due to a prior history of prostate cancer. The final study group for analysis of interview data consisted of 981 cases (479 black, 502 white) and 1315 controls (594 black, 721 white) ( Table 1) . Distributions of selected variables in this study group are shown in Table 2 .
Laboratory-based study
Cases of prostate cancer were eligible for blood collection, which occurred about 12 weeks after diagnosis, if they had not had chemotherapy, radiation therapy, treatment with hormone-related drugs, or orchiectomy prior to blood collection. A series of controls was also selected for blood collection based on the age and race distribution of the eligible cases. Venous blood (50 ml) was drawn and aliquoted to serum, plasma and red blood cell/buffy coat fractions. Blood products were stored in 1 ml vials at -70°C. Among interviewed subjects, blood samples were successfully drawn for serological assays (syphilis and human papillomavirus (HPV)) from 276 (57%) of the eligible cases and 295 (63%) of the eligible controls (Table 1) .
Specimens were tested in the microhaemagglutination assay for antibodies to Treponema pallidum (MHA-TP) (Kennedy, 1990) . Serum antibodies to human papillomavirus (HPV-16) were assayed by a validated enzyme-linked immunosorbent assay (ELISA), with positive reactivity defined by previously determined optical density cut-off values (Strickler et al, 1997 (Strickler et al, , 1999 . Approximately 85% of Interviewed subjects  594  721 1315  479  502 981  Eligible for serologic studies  213  254  467  234  251 485  Blood drawn  137  158  295  127  149 276   Table 2 Selected characteristics of interviewed prostate cancer cases and controls. Age  40-59  124  228  164  322  60-69  185  183  157  220  70 +  170  183  181  179   Study area  Atlanta  88  124  103  158  Detroit  180  246  223  268  New Jersey  211  224  176  295   Education  0-8th grade  199  215  55  89  9th-11th grade  118  133  87  97  12th +  161  246  359  529   Alcohol, drinks per week  Never  94  133  90  150  ≤7  96  126  136  213  8-21  113  168  140  197  22-56  119  118  92  124  ≥57  54  48  42  37   Cigarette use  Never used tobacco  88  116  86  149  Current cigarette use  161  221  116  177  Former cigarette use  189  199  243  319   Cancer stage  Localized  268  312  Regional  49  59  Distant  125  73  Unknown  26  42   Total subjects  479  594 individuals who have been infected with T. pallidum will maintain circulating antibodies that are detectable by the MHA-TP for a lifetime (Haas et al, 1990) . HPV capsid antibodies are also thought to exhibit long-term persistence (Carter et al, 1996) .
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Statistical analysis
Odds ratios for prostate cancer were estimated by unconditional logistic regression (Breslow and Day, 1980) . Adjustments for age, study site (Atlanta, Detroit, New Jersey), and, where appropriate, race were included in all logistic models. All categories were defined with common cut points for blacks and whites.
RESULTS
Interview study
Prostate cancer risk was increased among men who had a history of gonorrhoea or syphilis (OR = 1.6) ( Table 3 ). Risks increased with increasing number of occurrences of gonorrhoea (P for trend = 0.0005), rising to odds ratio (OR) = 3.3 among men with three or more events. The patterns of risk were similar for blacks and whites; however, these conditions were reported more commonly among blacks (18.7% vs 2.5% in controls). Greater risk was associated with first episodes of gonorrhoea at 20-29 years of age, as compared to first episodes at younger or older ages. Risks were similarly elevated among men reporting gonorrhoea only or syphilis only, but the risks were highest among men reporting both conditions. Risks associated with these diseases were similar for all cases combined and for those with advanced (regional/distant) stage (data not shown).
The risks associated with a history of syphilis or gonorrhea were highest among men less than 60 years of age at prostate cancer diagnosis (blacks, 39 cases, OR = 2.2, 95% confidence interval CI 1.3-3.6; whites, nine cases, OR = 1.8, 95% CI 0.7-4.5). The risks were less pronounced among black men at age 60-69 years (46 cases, OR = 1.5, 95% CI 0.9-2.4) and at age 70+ years (41 cases, OR = 1.4, 95% CI 0.8-2.4), while no excess risk was found among white men at age 60-69 years (four cases, OR = 1.0, 95% CI 0.3-4.0) or at age 70+ years (three cases, OR = 0.9, 95% CI 0.2-4.4). Among blacks, the greatest risks were found in Atlanta (31 cases, OR = 7.3; 95% CI 3.2-16.5), with lower risks in New Jersey (42 cases, OR = 1.5; 95% CI 0.9-2.4) and Detroit (53 cases, OR = 1.1; 95% CI 0.7-1.7). Among whites, the corresponding ORs for the three study sites were 1.1 (four cases, 95% CI 0.3-4.2), 1.9 (five cases, 95% CI 0.5-6.8), and 1.2 (seven cases, 95% CI 0.4-3.5).
Although syphilis and gonorrhoea were reported more often among men of lower SES (14% of controls) than among men of medium (7.3% of controls) or high SES (4.7% of controls), risks of prostate cancer associated with these disorders were similar for men of low (95 cases, OR = 1.5, 95% CI 1.1-2.1), medium (40 cases, OR = 1.6, 95% CI 1.0-2.8), or high SES (seven cases, OR = 1.7, 95% CI 0.6-5.4). The association with history of syphilis or gonorrhoea was also not changed by statistical adjustment for education. We previously found associations of prostate cancer in this study with family history of prostate cancer (Hayes et al, 1995) , heavy alcohol use (Hayes et al, 1997) , and intake of fat from animal sources (Hayes et al, 1999) , and weaker associations with cigarette use (Hayes et al, 1994) and vasectomy (Hayes et al, 1993) ; the association with history of syphilis or gonorrhoea was independent of these factors. Long-term use of condoms was associated with decreased risk of prostate cancer (Table 4) . Risks were increased among men who had frequent encounters with prostitutes or who failed to use condoms with prostitutes. Number of sexual partners (P trend < 0.0001) and frequency of encounters with prostitutes (P trend < 0.0001) were strongly associated with a reported history of syphilis or gonorrhoea (data not shown). However, the number of sexual partners was unrelated to prostate cancer risk. Risks were elevated among never-married black men (OR = 2.2; 95% CI 1.1-4.4) and among white men who had three or more marriages (OR = 1.8; 95% CI 1.0-3.4). Number of children was unrelated to risk. When assessed together in a multivariate model, risks for prostate cancer associated with history of syphilis or gonorrhoea, sexual encounters with prostitutes, years of condom use and number of sexual partners remained substantially unchanged.
No clear patterns of risk were associated with age at first sexual intercourse. Although the frequency of intercourse was not consistently associated with risk, there was a suggestive relationship in some age groups, notably with frequency of intercourse in the fifth decade (Table 5 ). However, many subjects failed to report on frequency of intercourse.
Serological study
Prostate cancer risk was increased among men with serologic evidence of infection with T. pallidum (OR = 1.8; 95% CI 1.0-3.5), particularly among blacks (Table 6 ). The evidence linking HPV-16 serology to prostate cancer was weaker (OR = 1.4; 95% CI 0.7-2.8), and derived mainly from excess risks among white men. Syphilis serology was associated with reported number of sexual partners (P trend = 0.009) and with frequency of encounters with prostitutes (P trend = 0.03). HPV serology, however, was not clearly related to these factors (P trend = 0.14 and P trend = 0.49, respectively). Serological evidence of syphilis (9.9% in black and 3.2% in white controls, Table 6 ) was more common than selfreports (2% in black and 0.1% in white controls, Table 3 ). Among subjects who replied to the question on history of syphilis and for whom serology results were available (268 cases, 280 controls), three (23%) of 13 reports of syphilis were confirmed by MHA-TP serology, while 42 (7.9%) of 535 subjects who reported no history of syphilis were serology-positive.
DISCUSSION
Our large population-based case-control study among US blacks and whites revealed an elevated risk of prostate cancer among men with a history of gonorrhoea or syphilis. Although STDs are not considered an established risk factor for prostate cancer (Nomura and Kolonel, 1991; Pienta and Esper, 1993; Ross and Schottenfeld, 1996) , the results from several (Steele et al, 1971; Krain, 1974; Heshmat et al, 1975; Lees et al, 1985; Mishina et al, 1985; Mandel and Schuman, 1987; Ross et al, 1987; Honda et al, 1988 ), but not all previous studies (Wynder et al, 1971 ) are consistent with our findings. We also observed a greater prevalence of antibodies to T. pallidum among prostate cancer cases than controls, suggesting that recall or reporting bias can not entirely explain the relationship with STDs observed in retrospective interview studies. The role of sexually transmitted factors in our study is suggested also by the excess risks of prostate cancer associated with frequent encounters with prostitutes and with failure to use condoms. Although some investigations have reported an Odds ratios, adjusted for age, study site and race. P for trend excludes unknowns.
increased risk associated with number of sexual partners (Steele et al, 1971; Krain, 1974; Anderson et al, 1996) , no relationship was seen in our study as well as others (Rotkin, 1977; Mandel and Schuman, 1987; Honda et al, 1988; La Vecchia et al, 1993) . It is unclear why excess risks have been associated with a history of STDs but not consistently with number of sexual partners, raising the possibility that STD-associated prostate cancer is confined to a subset of the sexually active population, in which ecological factors as well as individual behaviours influence transmission of an infectious agent (Koopman and Longini, 1994; Brunham and Plummer, 1990) . Gonorrhoea and syphilis were reported substantially more often among blacks (18.7%) than whites (2.5%) in our study, consistent with reports from national surveillance data systems (Nakashima et al, 1996; Division of STD Prevention, 1997) . However, the fraction of prostate cancer associated with syphilis or gonorrhoea (9.5% in blacks, 0.7% in whites) would account (assuming a causal relation) for a relatively small per cent of the black-white difference in cancer rates.
Since gonorrhoea and syphilis may be sentinels for a sexually transmitted infectious agent that contributes to the aetiology of prostate cancer, the risks we observed for STDs would only partially reflect the true risks associated with the putative agent. For example, only after sensitive and specific assays were developed for HPV did the relatively modest risks for cervical intraepithelial neoplasia associated with sexual activity (two-to fourfold) translate to the substantial (50-fold) risks now established for cervical disease due to specific HPV subtypes (Schiffman et al, 1993) . Although estimates of relative risk for prostate cancer were fairly consistent when measured by various definitions of sexually transmitted disease, population attributable risks remain uncertain as the prevalence estimates for STDs in our study varied substantially by disease type and by whether the method of ascertainment was by questionnaire or serology. Both questionnaire and serological measures are subject to measurement error (Romanowski et al, 1991; Anderson et al, 1994) .
Although subgroup analyses in our study were limited by small numbers, the risks associated with history of STDs were greatest among younger men (< 60 years of age) and among black men in Atlanta. The age effect may indicate differential susceptibility or perhaps greater misclassification of these conditions among older men. More intriguing is the geographic variation in view of the high prevalence of gonorrhoea and syphilis in the southeastern States (Thomas et al, 1996; Kilmarx et al, 1997) , as well as the elevated prostate cancer mortality rates among black men in this region (Devesa et al, 1999) . Although STDs are more common among men of lower social class (Nakashima et al, 1996; Kilmarx et al, 1997) , the relative risks for prostate cancer in our study did not vary by measures of SES, suggesting that the STD-associated risks are not simply an indicator of SES-related factors.
Microbiological and molecular studies to detect infectious agents that may induce prostate cancer have been inconclusive. HPV, which occurs in human prostate cancer and benign prostatic tissue (Cuzick, 1995; IARC, 1995) , has been shown to transform human prostate cells in vitro. Seropositivity for HPV-18 and HPV-16 has been associated with subsequent prostate cancer in a Finnish cohort study (Dillner et al, 1998) , but a small case-control study of HPV-16 and HPV-11 (Strickler et al, 1998) , and our serological investigation of HPV-16 showed little evidence of risk. Since HPV seropositivity is low in these studies (e.g. HPV-16 < 5%), larger investigations will be needed to clarify this relationship. While an excess of prostate cancer has been observed in men with anal cancer, which is linked to HPV infection (IARC, 1995) , the epidemiological patterns of HPV-related cervical cancer (Schiffman et al, 1996) are not closely correlated with prostate cancer, although one study reported increased occurrence of cervical cancer in spouses of prostate cancer patients (Feminella and Lattimer, 1974) . In addition, no case-control differences have been found with serological responses to herpes simplex, cytomegalovirus and Epstein-Barr virus (Baker et al, 1981; Mandel and Schuman, 1987; Anderson et al, 1996) , and studies of HHV8 RNA transcripts in prostate tumour tissue have been inconclusive (Staskus et al, 1997) .
Our findings should not be viewed as inconsistent with the widely held view that androgen metabolism plays an important role in prostate carcinogenesis, and that underlying hormonal factors may contribute to the relationship between sexual behaviour, STDs and prostate cancer risk. However, frequency of sexual intercourse was not clearly associated with prostate cancer risk in our study, as one might expect if hormonal factors were responsible for the relationships observed. Furthermore, the association between serum hormone levels and sexual activity among men with normal gonads is uncertain (Buena et al, 1993; Mantzoros et al, 1995; Bagatell and Bremmer, 1997) .
Further insight into the relationship between sexual behaviour and prostate cancer, and the mechanisms involved, may come from prospective epidemiological studies that employ hormonal, microbial and other potential biomarkers of risk. Although a search for infectious agents in unselected prostate tumour tissue has been uninformative to date, study of tumour tissue from men with a history of STDs might prove useful. In summary, our case-control study of prostate cancer among US blacks and whites revealed excess risks among men who reported a history of gonorrhoea or syphilis, had a positive serology for syphilis, or reported certain sexual behaviours that predispose to these conditions. Although a history of STDs appears associated with a relatively small number of prostate cancers, the findings suggest the need to expand the search for a sexually transmitted agent as well as hormonal and other factors that may contribute to the aetiology of these tumours.
